Pharma & Healthcare·Stocks·USA Eli Lilly Weight Loss +5.2%: Rally Following Study Shock at Novo Nordisk Feb 23, 2026
Tech & AI·Stocks·USA Salesforce Quarter -4.3%: AI Offensive Between Opportunity and Crash Warning Feb 23, 2026
Pharma & Healthcare·Stocks·Europe Novo Nordisk CagriSema -15%: Study Shock Causes Stock Plunge Feb 23, 2026
Pharma & Healthcare·Stocks·USA Merck Dividend Strategy Opportunity: Can It Withstand the Keytruda Patent Shock in 2028? Feb 22, 2026
Tech & AI·Stocks·USA Amazon AI Investments $200B: Opportunity for AWS or Cash Flow Shock? Feb 22, 2026
